Single User License
INR 102030
Site License
INR 204060
Corporate User License
INR 306090

Service Tax Additional

select a format
Price

Single User License
USD 1500
Site License
USD 3000
Corporate User License
USD 4500

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"


Reata Pharmaceuticals, Inc.-Product Pipeline Review-2015

Reata Pharmaceuticals, Inc.-Product Pipeline Review-2015


  Request for Sample Report

Executive Summary

Reata Pharmaceuticals, Inc.-Product Pipeline Review-2015

Summary

Global Markets Direct's, 'Reata Pharmaceuticals, Inc.-Product Pipeline Review-2015', provides an overview of the Reata Pharmaceuticals, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Reata Pharmaceuticals, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides brief overview of Reata Pharmaceuticals, Inc. including business description, key information and facts, and its locations and subsidiaries

The report reviews current pipeline of Reata Pharmaceuticals, Inc.'s human therapeutic division and enlists all their major and minor projects

The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones

Special feature on out-licensed and partnered product portfolio

The report summarizes all the dormant and discontinued pipeline projects

Latest company statement

Latest news and deals relating to the Reata Pharmaceuticals, Inc.'s pipeline products

Reasons To Buy

Evaluate Reata Pharmaceuticals, Inc.'s strategic position with total access to detailed information on its product pipeline

Assess the growth potential of Reata Pharmaceuticals, Inc. in its therapy areas of focus

Identify new drug targets and therapeutic classes in the Reata Pharmaceuticals, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas

Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps

Develop strategic initiatives by understanding the focus areas of Reata Pharmaceuticals, Inc. and exploit collaboration and partnership opportunities

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Plan mergers and acquisitions effectively by identifying the most promising pipeline of Reata Pharmaceuticals, Inc.

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Explore the dormant and discontinued projects of Reata Pharmaceuticals, Inc. and identify potential opportunities in those areas

Avoid Intellectual Property Rights related issues

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Reata Pharmaceuticals, Inc. Snapshot 5

Reata Pharmaceuticals, Inc. Overview 5

Key Information 5

Key Facts 5

Reata Pharmaceuticals, Inc.-Research and Development Overview 6

Key Therapeutic Areas 6

Reata Pharmaceuticals, Inc.-Pipeline Review 9

Pipeline Products by Stage of Development 9

Pipeline Products-Monotherapy 10

Pipeline Products-Partnered Products 11

Partnered Products/Combination Treatment Modalities 12

Reata Pharmaceuticals, Inc.-Pipeline Products Glance 13

Reata Pharmaceuticals, Inc.-Clinical Stage Pipeline Products 13

Phase II Products/Combination Treatment Modalities 13

Phase I Products/Combination Treatment Modalities 14

Reata Pharmaceuticals, Inc.-Early Stage Pipeline Products 15

Preclinical Products/Combination Treatment Modalities 15

Discovery Products/Combination Treatment Modalities 16

Reata Pharmaceuticals, Inc.-Drug Profiles 17

RTA-408 17

Product Description 17

Mechanism of Action 17

R&D Progress 17

bardoxolone methyl 20

Product Description 20

Mechanism of Action 20

R&D Progress 20

RTA-301 23

Product Description 23

Mechanism of Action 23

R&D Progress 23

RTA-801 24

Product Description 24

Mechanism of Action 24

R&D Progress 24

Small Molecule for Parkinson's Disease 25

Product Description 25

Mechanism of Action 25

R&D Progress 25

Small Molecules to Activate Nrf2 for Duchenne Muscular Dystrophy 26

Product Description 26

Mechanism of Action 26

R&D Progress 26

Small Molecules to Activate Nrf2 for Rheumatoid Arthritis 27

Product Description 27

Mechanism of Action 27

R&D Progress 27

Small Molecule to Activate Nrf2 for Cystic Fibrosis 28

Product Description 28

Mechanism of Action 28

R&D Progress 28

Small Molecules to Activate CFTR for Cystic Fibrosis 29

Product Description 29

Mechanism of Action 29

R&D Progress 29

Reata Pharmaceuticals, Inc.-Pipeline Analysis 30

Reata Pharmaceuticals, Inc.-Pipeline Products by Target 30

Reata Pharmaceuticals, Inc.-Pipeline Products by Route of Administration 31

Reata Pharmaceuticals, Inc.-Pipeline Products by Molecule Type 32

Reata Pharmaceuticals, Inc.-Pipeline Products by Mechanism of Action 33

Reata Pharmaceuticals, Inc.-Recent Pipeline Updates 34

Reata Pharmaceuticals, Inc.-Dormant Projects 37

Reata Pharmaceuticals, Inc.-Discontinued Pipeline Products 38

Discontinued Pipeline Product Profiles 38

bardoxolone methyl 38

Reata Pharmaceuticals, Inc.-Locations And Subsidiaries 39

Head Office 39

Appendix 40

Methodology 40

Coverage 40

Secondary Research 40

Primary Research 40

Expert Panel Validation 40

Contact Us 40

Disclaimer 41

List of Tables

Reata Pharmaceuticals, Inc., Key Information 5

Reata Pharmaceuticals, Inc., Key Facts 5

Reata Pharmaceuticals, Inc.-Pipeline by Indication, 2015 8

Reata Pharmaceuticals, Inc.-Pipeline by Stage of Development, 2015 9

Reata Pharmaceuticals, Inc.-Monotherapy Products in Pipeline, 2015 10

Reata Pharmaceuticals, Inc.-Partnered Products in Pipeline, 2015 11

Reata Pharmaceuticals, Inc.-Partnered Products/ Combination Treatment Modalities, 2015 12

Reata Pharmaceuticals, Inc.-Phase II, 2015 13

Reata Pharmaceuticals, Inc.-Phase I, 2015 14

Reata Pharmaceuticals, Inc.-Preclinical, 2015 15

Reata Pharmaceuticals, Inc.-Discovery, 2015 16

Reata Pharmaceuticals, Inc.-Pipeline by Target, 2015 30

Reata Pharmaceuticals, Inc.-Pipeline by Route of Administration, 2015 31

Reata Pharmaceuticals, Inc.-Pipeline by Molecule Type, 2015 32

Reata Pharmaceuticals, Inc.-Pipeline Products by Mechanism of Action, 2015 33

Reata Pharmaceuticals, Inc.-Recent Pipeline Updates, 2015 34

Reata Pharmaceuticals, Inc.-Dormant Developmental Projects,2015 37

Reata Pharmaceuticals, Inc.-Discontinued Pipeline Products, 2015 38

List of Figures

Reata Pharmaceuticals, Inc.-Pipeline by Top 10 Indication, 2015 7

Reata Pharmaceuticals, Inc.-Pipeline by Stage of Development, 2015 9

Reata Pharmaceuticals, Inc.-Monotherapy Products in Pipeline, 2015 10

Reata Pharmaceuticals, Inc.-Pipeline by Top 10 Target, 2015 30

Reata Pharmaceuticals, Inc.-Pipeline by Top 10 Route of Administration, 2015 31

Reata Pharmaceuticals, Inc.-Pipeline by Top 10 Molecule Type, 2015 32

Reata Pharmaceuticals, Inc.-Pipeline Products by Top 10 Mechanism of Action, 2015 33

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Current R&D Portfolio of Reata Pharmaceuticals, Inc.; Reata Pharmaceuticals, Inc. - Key Therapeutics; Reata Pharmaceuticals, Inc. - Pipeline Overview and Promising Molecules; Reata Pharmaceuticals, Inc. - News; Reata Pharmaceuticals, Inc. - Latest Updates; Reata Pharmaceuticals, Inc. - Pipeline; Reata Pharmaceuticals, Inc. - Discontinued/Dormant Projects


Related Products in vertical
Other reports by publisher
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com